Basic Materials / Specialty ChemicalsShanghai
$29.11
+0.13 (+0.45%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 35% · confianza 11%
FCF escenarios
weak_data · normalized FCF $-1.4B · quality 23.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
19/100
F
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$3.9B
P/E
153.2x
↑EV/EBITDA
82.2x
↑ROE
0.7%
↑Gross Margin
13.7%
↓Debt/Equity
2.25
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-2.2%
FCF CAGR
—
FCF margin
-307.4%
FCF / Net income
-226.23x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $840.5M · net income $11.4M · FCF $-2.58B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $840.5M | $840.5M | $780.8M | $756.6M | $899.8M |
| Net Income | $11.4M | $11.4M | $-12.1M | $61.4M | $110.1M |
| EBITDA | $92.7M | $92.7M | $52.4M | $127.0M | $170.1M |
| EPS | 0.08 | 0.08 | -0.09 | 0.46 | 0.99 |
| Gross Margin | 13.7% | 13.7% | 13.9% | 21.3% | 24.2% |
| Operating Margin | 1.8% | 1.8% | -0.9% | 8.2% | 15.0% |
| Net Margin | 1.4% | 1.4% | -1.6% | 8.1% | 12.2% |
| Balance Sheet | |||||
| Debt/Equity | 2.25 | 2.25 | 0.67 | 0.18 | 0.05 |
| Current Ratio | 0.72 | 0.72 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-2.58B | $-2.58B | $-1.40B | $-132.0M | $-61.4M |
| Returns | |||||
| ROE | 0.7% | 0.7% | -0.8% | 3.9% | 7.3% |
| Valuation | |||||
| P/E | 153.21 | 153.21 | — | 77.41 | 48.59 |
| EV/EBITDA | 82.19 | 82.19 | 97.71 | 35.43 | 29.40 |
| P/B | 2.64 | 2.64 | 2.72 | 2.98 | 3.55 |
| Growth & Yield | |||||
| Revenue Growth | 7.7% | 7.7% | 3.2% | -15.9% | — |
| EPS Growth | 188.9% | 188.9% | -119.6% | -53.5% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
218.4%
EPS terminal req.
$2.58
Spread vs growth
-29.5%
5Y implied EPS CAGR
108.1%
EPS terminal req.
$3.13
Spread vs growth
80.7%
10Y implied EPS CAGR
51.3%
EPS terminal req.
$5.03
Spread vs growth
137.6%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+14.6%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.09 → 0.08
Residual
+14.6%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.